MEDIO logo

Medistim OM:MEDIO Stock Report

Last Price

NOK 131.00

Market Cap

NOK 2.4b

7D

-8.7%

1Y

n/a

Updated

20 Nov, 2024

Data

Company Financials +

MEDIO Stock Overview

Develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. More details

MEDIO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Medistim ASA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medistim
Historical stock prices
Current Share PriceNOK 131.00
52 Week HighNOK 181.50
52 Week LowNOK 131.00
Beta0.99
11 Month Change-23.84%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-25.14%

Recent News & Updates

Recent updates

Shareholder Returns

MEDIOSE Medical EquipmentSE Market
7D-8.7%-2.4%-1.9%
1Yn/a-4.1%12.5%

Return vs Industry: Insufficient data to determine how MEDIO performed against the Swedish Medical Equipment industry.

Return vs Market: Insufficient data to determine how MEDIO performed against the Swedish Market.

Price Volatility

Is MEDIO's price volatile compared to industry and market?
MEDIO volatility
MEDIO Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.4%
Market Average Movement5.5%
10% most volatile stocks in SE Market11.2%
10% least volatile stocks in SE Market3.3%

Stable Share Price: MEDIO's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: Insufficient data to determine MEDIO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984151Kari Krogstadwww.medistim.com

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis.

Medistim ASA Fundamentals Summary

How do Medistim's earnings and revenue compare to its market cap?
MEDIO fundamental statistics
Market capNOK 2.42b
Earnings (TTM)NOK 101.64m
Revenue (TTM)NOK 541.82m

23.8x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEDIO income statement (TTM)
RevenueNOK 541.82m
Cost of RevenueNOK 114.23m
Gross ProfitNOK 427.60m
Other ExpensesNOK 325.96m
EarningsNOK 101.64m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.55
Gross Margin78.92%
Net Profit Margin18.76%
Debt/Equity Ratio0%

How did MEDIO perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

81%

Payout Ratio